Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase

被引:90
|
作者
Waki, M [1 ]
Yoshida, Y [1 ]
Oka, T [1 ]
Azuma, M [1 ]
机构
[1] Senju Pharmaceut Co Ltd, Res Lab, Nishi Ku, Kobe, Hyogo 6512241, Japan
关键词
Rho-associated protein kinase; ROCK inhibitor; instillation; intraocular pressure (IOP); glaucoma;
D O I
10.1076/ceyr.22.6.470.5489
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Rho-associated coiled coil-forming protein kinase (ROCK) is a downstream target of a small GTPase, Rho. The kinase has been reported to regulate actomyosin-based contractility of smooth muscles by modulation of myosin phosphatase activity. Contractility of ciliary muscle could be implicated in regulation of intraocular pressure while that of ocular vessels could affect blood flow to retina. The present study has been performed to investigate the effect of a ROCK inhibitor on intraocular pressure in rabbits. Methods. An inhibitor of ROCK, Y-27632, was dissolved in an ophthalmic solution and topically administered to the eye of a Japanese white rabbit. Intraocular pressure was measured by pneumatonography (n = 12, 24 eyes). Constriction of ciliary muscle was measured by the Magnus method using 12 eyes. Results. Topical application of 0.1 and 0.03% Y-27632 significantly decreased the intraocular pressure, with maximum decreases of 5.3 and 4.3 mmHg after 90 minutes compared with the control eye. Y-27632 inhibited the carbachol-induced constriction of rabbit ciliary muscle. Conclusions. The ROCK inhibitor reduced intraocular pressure in rabbits by topical instillation. The inhibitor relaxed the excised ciliary muscle which was previously constricted by carbachol suggesting that the inhibitor acts to increase the uveoscleral outflow. Our results suggest that the ROCK inhibitor is a promising treatment for glaucoma therapy in the next generation.
引用
收藏
页码:470 / 474
页数:5
相关论文
共 50 条
  • [21] Epigenetic Control of Rho-Associated Protein Kinase 2 in Neurodegeneration
    Chen, Bing
    Zheng, Weiming
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (03) : 815 - 822
  • [22] Regulation of myosin phosphatase by Rho and Rho-Associated kinase (Rho-kinase)
    Kimura, K
    Ito, M
    Amano, M
    Chihara, K
    Fukata, Y
    Nakafuku, M
    Yamamori, B
    Feng, JH
    Nakano, T
    Okawa, K
    Iwamatsu, A
    Kaibuchi, K
    SCIENCE, 1996, 273 (5272) : 245 - 248
  • [24] Rho/Rho-associated kinase pathway in glaucoma (Review)
    Wang, Jing
    Liu, Xiaohong
    Zhong, Yisheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (05) : 1357 - 1367
  • [25] Regulation and functions of Rho-associated kinase
    Amano, M
    Fukata, Y
    Kaibuchi, K
    EXPERIMENTAL CELL RESEARCH, 2000, 261 (01) : 44 - 51
  • [26] Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C
    Kang, Jeong-Hun
    Jiang, Yuhua
    Toita, Riki
    Oishi, Jun
    Kawamura, Kenji
    Han, Aishan
    Mori, Takeshi
    Niidome, Takuro
    Ishida, Masami
    Tatematsu, Kenji
    Tanizawa, Katsuyuki
    Katayama, Yoshiki
    BIOCHIMIE, 2007, 89 (01) : 39 - 47
  • [27] Topical Rho-Associated Kinase Inhibitor, Y27632, Accelerates Corneal Endothelial Regeneration in a Canine Cryoinjury Model
    Miyagi, Hidetaka
    Kim, Soohyun
    Li, Jennifer
    Murphy, Christopher J.
    Thomasy, Sara M.
    CORNEA, 2019, 38 (03) : 352 - 359
  • [28] Effects of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on Optic Nerve Head Blood Flow in Rabbits
    Sugiyama, Tetsuya
    Shibata, Maho
    Kajiura, Sumiko
    Okuno, Takashi
    Tonari, Masahiro
    Oku, Hidehiro
    Ikeda, Tsunehiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (01) : 64 - 69
  • [29] Prevention of Collagen Scaffold Contraction using an Inhibitor of Rho-associated Protein Kinase Y-27632
    Versteegden, L. R.
    Raave, R.
    Ripmeester, E. G.
    Tsiapalis, D.
    van Kuppevelt, T. H.
    Daamen, W. F.
    TISSUE ENGINEERING PART A, 2015, 21 : S204 - S205
  • [30] ITRI-E-247, a novel selective Rho-associated kinase inhibitor, characterized with the potent intraocular pressure lowering effect and less conjunctival hyperemia
    Tu, Chiamu
    Liu, Chih-Peng
    Chen, ChihHung
    Tsai, Yuan-Jang
    Hwang, Chrong-Shiong
    Hung, Chiu-Lien
    Chen, Yi-Hsun
    Hu, Tsan-Lin
    Chou, Shuen-Hsiang
    Chen, Sung-En
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)